Drug for Pancreatic Cancer Developed by College of Pharmacy Researchers (IMAGE)
Caption
University of Houston researchers Ruiwen Zhang, M.D., Ph.D. and Robert L. Boblitt Endowed Professor in Drug Discovery, left, and research associate professor of pharmacology Wei Wang, M.D., Ph.D., have developed a drug that can inhibit two of the major pathways of deadly pancreatic cancer.
Credit
University of Houston
Usage Restrictions
None
License
Licensed content